Lantern Pharma Inc (LTRN)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
15,596,700
EV to revenue ratio (TTM)
EV to ebitda
0.214
Financial Performance
Revenue (TTM)
0
Gross profit (TTM)
0
EBITDA
-15,450,090
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-74.30%
Return on equity (TTM)
-400.90%
Per Share Metrics
Revenue per share (TTM)
0
EPS
-1.63
Diluted EPS (TTM)
-1.63
Book value
-0.25
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
Price to book ratio (TTM)
9.74
Growth
Quarterly earnings growth (YoY)
0.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
2.299